La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

U.S. Physical Therapy Croissance future

Future contrôle des critères 3/6

U.S. Physical Therapy devrait augmenter ses bénéfices et son chiffre d'affaires de 37.1% et de 6.6% par an respectivement. Le BPA devrait croître de de 36.7% par an. Le rendement des capitaux propres devrait être 9.2% dans 3 ans.

Informations clés

37.1%

Taux de croissance des bénéfices

36.7%

Taux de croissance du BPA

Healthcare croissance des bénéfices	19.3%
Taux de croissance des recettes	6.6%
Rendement futur des capitaux propres	9.2%
Couverture par les analystes	Good
Dernière mise à jour	15 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

U.S. Physical Therapy acquires physical therapy practice for $19.3M

Nov 01

U.S. Physical Therapy says Hurricane Ian affected about 50 clinics, ~$395K in lost sales

Oct 17

What Is U.S. Physical Therapy, Inc.'s (NYSE:USPH) Share Price Doing?

Oct 05

U.S. Physical Therapy acquires two-clinic practice

Oct 03

Prévisions de croissance des bénéfices et des revenus

NYSE:USPH - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	739	51	88	90	2
12/31/2025	690	45	72	86	6
12/31/2024	657	35	83	92	4
6/30/2024	621	16	68	77	N/A
3/31/2024	606	18	66	75	N/A
12/31/2023	599	18	73	82	N/A
9/30/2023	585	24	64	72	N/A
6/30/2023	575	26	62	70	N/A
3/31/2023	564	28	50	58	N/A
12/31/2022	548	29	50	59	N/A
9/30/2022	536	39	48	57	N/A
6/30/2022	522	38	59	68	N/A
3/31/2022	509	37	61	70	N/A
12/31/2021	490	31	68	76	N/A
9/30/2021	477	31	78	86	N/A
6/30/2021	461	30	81	87	N/A
3/31/2021	418	32	95	101	N/A
12/31/2020	418	32	92	100	N/A
9/30/2020	423	30	82	91	N/A
6/30/2020	431	31	72	82	N/A
3/31/2020	473	29	55	65	N/A
12/31/2019	477	31	52	62	N/A
9/30/2019	472	30	56	65	N/A
6/30/2019	468	23	62	71	N/A
3/31/2019	457	18	63	71	N/A
12/31/2018	449	17	66	73	N/A
9/30/2018	442	18	63	70	N/A
6/30/2018	432	22	58	65	N/A
3/31/2018	421	21	N/A	58	N/A
12/31/2017	410	22	N/A	57	N/A
9/30/2017	392	20	N/A	53	N/A
6/30/2017	377	20	N/A	42	N/A
3/31/2017	363	21	N/A	51	N/A
12/31/2016	353	21	N/A	51	N/A
9/30/2016	348	20	N/A	48	N/A
6/30/2016	344	21	N/A	49	N/A
3/31/2016	337	21	N/A	49	N/A
12/31/2015	327	21	N/A	38	N/A
9/30/2015	320	21	N/A	45	N/A
6/30/2015	313	20	N/A	43	N/A
3/31/2015	308	20	N/A	45	N/A
12/31/2014	301	19	N/A	41	N/A
9/30/2014	290	19	N/A	45	N/A
6/30/2014	278	18	N/A	45	N/A
3/31/2014	267	18	N/A	44	N/A
12/31/2013	260	18	N/A	45	N/A
9/30/2013	253	18	N/A	39	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de USPH ( 37.1% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de USPH ( 37.1% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).

Croissance élevée des bénéfices: Les bénéfices de USPH devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de USPH ( 6.6% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de USPH ( 6.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de USPH devrait être faible dans 3 ans ( 9.2 %).

U.S. Physical Therapy Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Price target increased by 9.0% to US$119

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

Price target decreased by 7.9% to US$118

Price target increased by 7.9% to US$119

Price target increased by 7.5% to US$110

Recent updates

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

First quarter dividend of US$0.44 announced

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Chief Operating Officer - West recently sold US$452k worth of stock

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Chief Operating Officer - West notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

Price target increased by 7.9% to US$119

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Independent Director recently sold US$463k worth of stock

Executive VP recently sold US$92k worth of stock

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Upcoming dividend of US$0.43 per share at 1.7% yield

Price target increased by 7.5% to US$110

Full year 2022 earnings: EPS misses analyst expectations

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit